Grant Backs CRISPR Therapy Research for Familial ALS

Grant Backs CRISPR Therapy Research for Familial ALS

295298

Grant Backs CRISPR Therapy Research for Familial ALS

Researchers at the University of Texas at Dallas (UT Dallas) have received an award from the U.S. Army Medical Research Acquisition Activity to advance their preclinical research of an innovative CRISPR-based gene editing approach to treat one of the most common causes of familial amyotrophic lateral sclerosis (ALS). The two-year award of nearly $650,000 was granted to the project’s principal investigator, Zhenghong Gao, PhD, a mechanical engineering research scientist at UT Dallas’ Erik Jonsson School of…

You must be logged in to read/download the full post.